Sickle Cell Hope: Two Gene Therapies Approved by FDA, Bringing Relief to Patients
The US Food and Drug Administration (FDA) has approved two gene-based treatments for sickle cell disease, marking a pivotal moment in the realm of genetic therapies. Among them is Casgevy, the first therapy leveraging the revolutionary…